Overview
Lung cancer is malignant neoplasia arising from the cells of the lung, and it is the leading cause of cancer-related death worldwide. It is broadly divided into two principal categories, non-small-cell lung cancer, which includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, and small cell lung cancer, an aggressive neuroendocrine form, the two differing in biology, growth pattern, and treatment. Tobacco smoking is the dominant risk factor and accounts for the majority of cases, while additional contributors include second-hand smoke, occupational and environmental carcinogens such as radon and asbestos, air pollution, and genetic susceptibility, all relevant to the epidemiology and prevention of the disease. Pathogenesis proceeds through accumulated genetic and epigenetic alterations that disrupt growth control and promote invasion and metastasis to sites including the adrenal glands, brain, bone, and liver. Strategies for prevention, screening, and early detection aim to reduce incidence and mortality, while stage-directed management combines surgery, radiotherapy, systemic chemotherapy, molecularly targeted therapy, and immunotherapy, supported by adjunctive care such as nutritional support in cachexia. The journal publishes peer-reviewed research relevant to this area, with work addressing methods for prevention, diagnosis, and management of lung cancer, surgical resection strategies alongside immunotherapy, adrenal metastasis, the influence of statins and anticoagulants, biomarker detection platforms, and nutritional support in cachexia, reflecting epidemiological, preventive, therapeutic, and supportive dimensions of lung cancer.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Immunotherapy Usage Has Not Increased Sub-Lobar Pulmonary Resections Despite Reduced Pneumonectomies
Lung Cancer and Isolated Adrenal Metastases: Different Disease?
Statins and Lung Cancer: A Review of Current Literature
The Role of Heparin in Lung Cancer
Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
High-Throughput Complex Disease Modeling for Ethical Drug Discovery: Clinical Relevance of a NAM Platform for Cancer Biomarker Development
Evolution of the Solid Human Tumor Cells Properties in Various Experimental Systems in Vitro
Thyroid Transcription Factor-1 Activity is Required for the Proliferation of Human Thyroid Cancer Cells 8505C
Overexpression of Prostate Apoptosis Response Protein-4 In Colon Cancer Cells Can Inhibit Metastasis by Upregulating E-cadherin Expression
Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
How this research is being cited
The 12 articles above have been cited 22 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Discover Oncology
-
2025 · Discover Oncology
-
2023 · Siberian Journal of Oncology
-
2023 · Siberian journal of oncology
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
2022 · Effective Pharmacotherapy
-
2022 · Cancers
-
2022 · Cancers
A sample of recent works citing this journal's research on Lung Cancer, linking to each citing work.